Cannara Biotech Inc. (TSXV:LOVE)

Cannara Biotech Revenue

Cannara Biotech had revenue of 27.27M CAD in the quarter ending May 31, 2025, with 40.01% growth. This brings the company's revenue in the last twelve months to 101.87M, up 33.09% year-over-year. In the fiscal year ending August 31, 2024, Cannara Biotech had annual revenue of 81.75M with 42.77% growth.

• Revenue (ttm): 101.87M
• Revenue Growth: +33.09%
• P/S Ratio: 1.64
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 175.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2024	81.75M	24.49M	42.77%
Aug 31, 2023	57.26M	21.42M	59.76%
Aug 31, 2022	35.84M	18.82M	110.58%
Aug 31, 2021	17.02M	14.47M	567.24%
Aug 31, 2020	2.55M	453.88K	21.64%